His primary scientific interests are in Staphylococcus aureus, Microbiology, Vancomycin, Antibiotics and Antibacterial agent. George Sakoulas has included themes like Bacteremia and Immunology in his Staphylococcus aureus study. In his study, Surgery and Methicillin Susceptible Staphylococcus Aureus is inextricably linked to Internal medicine, which falls within the broad field of Bacteremia.
His Microbiology study combines topics in areas such as Methicillin-resistant Staphylococcus aureus and Linezolid. His Linezolid research incorporates themes from Ribosomal RNA, Antimicrobial and Peritonitis. A large part of his Vancomycin studies is devoted to Daptomycin.
His primary areas of investigation include Microbiology, Staphylococcus aureus, Daptomycin, Vancomycin and Antibiotics. His Microbiology study frequently links to other fields, such as Linezolid. His research integrates issues of Bacteremia and Immunology in his study of Staphylococcus aureus.
His research investigates the connection between Daptomycin and topics such as Enterococcus faecium that intersect with problems in Ampicillin and Enterococcus faecalis. His Vancomycin research is multidisciplinary, incorporating elements of Nafcillin, Antibacterial agent, Meticillin, Minimum inhibitory concentration and Pharmacotherapy. As a part of the same scientific family, George Sakoulas mostly works in the field of Antibiotics, focusing on Acinetobacter baumannii and, on occasion, Colistin.
His primary areas of study are Bacteremia, Staphylococcus aureus, Internal medicine, Microbiology and Methicillin-resistant Staphylococcus aureus. In general Staphylococcus aureus study, his work on Linezolid often relates to the realm of Ticagrelor, thereby connecting several areas of interest. The study incorporates disciplines such as Gastroenterology and Staphylococcus aureus bacteremia in addition to Internal medicine.
His work on Antibiotics and Azithromycin as part of general Microbiology research is frequently linked to Membrane vesicle, thereby connecting diverse disciplines of science. He combines subjects such as Antimicrobial, Immunology and Biofilm with his study of Antibiotics. The Methicillin-resistant Staphylococcus aureus study combines topics in areas such as Vancomycin, Daptomycin and Combination therapy.
His scientific interests lie mostly in Internal medicine, Methicillin-resistant Staphylococcus aureus, Bacteremia, Antibiotics and Vancomycin. His study on Methicillin-resistant Staphylococcus aureus is covered under Staphylococcus aureus. His study in Staphylococcus aureus is interdisciplinary in nature, drawing from both Cellulitis and Adverse effect.
Antibiotics is a subfield of Microbiology that George Sakoulas studies. His Microbiology research integrates issues from Oritavancin and Acinetobacter baumannii. Daptomycin is the focus of his Vancomycin research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible staphylococcus aureus bacteremia: A meta-analysis
Sara E. Cosgrove;George Sakoulas;Eli N. Perencevich;Mitchell J. Schwaber.
Clinical Infectious Diseases (2003)
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Sotirios Tsiodras;Sotirios Tsiodras;Howard S Gold;Howard S Gold;George Sakoulas;George Sakoulas;George M Eliopoulos;George M Eliopoulos.
The Lancet (2001)
Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
George Sakoulas;Pamela A. Moise-Broder;Jerome Schentag;Alan Forrest.
Journal of Clinical Microbiology (2004)
Accessory Gene Regulator (agr) Locus in Geographically Diverse Staphylococcus aureus Isolates with Reduced Susceptibility to Vancomycin
George Sakoulas;George M. Eliopoulos;Robert C. Moellering;Christine Wennersten.
Antimicrobial Agents and Chemotherapy (2002)
Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy
Pamela A. Moise-Broder;George Sakoulas;George M. Eliopoulos;Jerome J. Schentag.
Clinical Infectious Diseases (2004)
Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.
Vance G. Fowler;George Sakoulas;Lauren M. McIntyre;Lauren M. McIntyre;Venkata G. Meka.
The Journal of Infectious Diseases (2004)
Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding
Tiffanny Jones;Michael R. Yeaman;Michael R. Yeaman;Michael R. Yeaman;George Sakoulas;Soo-Jin Yang.
Antimicrobial Agents and Chemotherapy (2008)
Increasing Antibiotic Resistance among Methicillin-Resistant Staphylococcus aureus Strains
George Sakoulas;Robert C. Moellering.
Clinical Infectious Diseases (2008)
Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin
George Sakoulas;Jeff Alder;Claudie Thauvin-Eliopoulos;Robert C. Moellering.
Antimicrobial Agents and Chemotherapy (2006)
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus Bacteremia
Pamela A. Moise;George Sakoulas;Alan Forrest;Jerome J. Schentag.
Antimicrobial Agents and Chemotherapy (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: